Search hospitals > Ontario > TORONTO
Sunnybrook Health Sciences Centre
Claim this profileTORONTO, Ontario M4N 3M5
Global Leader in Breast Cancer
Global Leader in Prostate Cancer
Conducts research for Alzheimer's Disease
Conducts research for Depression
Conducts research for Stroke
803 reported clinical trials
108 medical researchers
Summary
Sunnybrook Health Sciences Centre is a medical facility located in TORONTO, Ontario. This center is recognized for care of Breast Cancer, Prostate Cancer, Alzheimer's Disease, Depression, Stroke and other specialties. Sunnybrook Health Sciences Centre is involved with conducting 803 clinical trials across 929 conditions. There are 108 research doctors associated with this hospital, such as Sandra Black, MD, Paul Karanicolas, MD, PhD, Gregory J Czarnota, PhD, MD, and Andrew Loblaw, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Prostate Cancer
Global LeaderStage IV
GRPR positive
ER positive
Top PIs
Sandra Black, MDSunnybrook Health Sciences Centre6 years of reported clinical research
Studies Alzheimer's Disease
Studies Mild Cognitive Impairment
11 reported clinical trials
22 drugs studied
Paul Karanicolas, MD, PhDSunnybrook Health Sciences Centre8 years of reported clinical research
Studies Cancer
Studies Surgery
9 reported clinical trials
21 drugs studied
Gregory J Czarnota, PhD, MDSunnybrook Health Sciences Centre1 year of reported clinical research
Studies Breast Cancer
Studies Head and Neck Cancers
9 reported clinical trials
14 drugs studied
Andrew Loblaw, MDSunnybrook Health Sciences Centre7 years of reported clinical research
Studies Prostate Cancer
Studies Uterine Tumors
8 reported clinical trials
10 drugs studied
Clinical Trials running at Sunnybrook Health Sciences Centre
Breast Cancer
Age-Related Macular Degeneration
Brain Tumor
Glioblastoma
Prostate Cancer
Atrial Fibrillation
Carcinoid Tumor
Ovarian Cancer
Cardiovascular Disease
Coronavirus
Blood Test
for Breast Cancer
The goal of this observational study is to assess the effectiveness of the mDETECT breast cancer blood test at monitoring treatment response in women with metastatic breast cancer undergoing treatment.
Recruiting1 award N/A1 criteria
Ultrasound-Enhanced Radiation Therapy
for Breast Cancer
The objective of this study is to demonstrate the feasibility of novel Magnetic Resonance Imaging (MRI)-guided ultrasound stimulated microbubble treatment to enhance radiation effects in humans receiving external beam radiotherapy delivered using a LINAC (linear accelerator) radiation therapy device.
Recruiting1 award Phase 17 criteria
Disitamab Vedotin + Tucatinib
for Breast Cancer
This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood. Once they've grown bigger in one spot or spread to other parts of the body, they're harder to treat. This is called advanced or metastatic cancer. Participants in this study must have breast cancer or gastric cancer. Participants must have tumors that have HER2 on them. This allows the cancer to grow more quickly or spread faster. There are few treatment options for patients with advanced or metastatic solid tumors that express HER2. This clinical trial uses an experimental drug called disitamab vedotin (DV). Disitamab vedotin is a type of antibody drug conjugate or ADC. ADCs are designed to stick to cancer cells and kill them. This clinical trial uses a drug called tucatinib, which has been approved to treat cancer in the United States and some other countries. This drug is sold under the brand name TUKYSA®. This study will test how safe and how well DV with tucatinib works for participants with solid tumors. This study will also test what side effects happen when participants take these drugs. A side effect is anything a drug does to the body besides treating the disease.
Recruiting1 award Phase 26 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sunnybrook Health Sciences Centre?
Sunnybrook Health Sciences Centre is a medical facility located in TORONTO, Ontario. This center is recognized for care of Breast Cancer, Prostate Cancer, Alzheimer's Disease, Depression, Stroke and other specialties. Sunnybrook Health Sciences Centre is involved with conducting 803 clinical trials across 929 conditions. There are 108 research doctors associated with this hospital, such as Sandra Black, MD, Paul Karanicolas, MD, PhD, Gregory J Czarnota, PhD, MD, and Andrew Loblaw, MD.
Where is Sunnybrook Health Sciences Centre located?
Sunnybrook Health Sciences Centre is situated at 2075 Bayview Ave, Toronto, ON M4N 3M5, close to the Bayview Ave and Eglinton Ave E intersection. It also offers an underground parking garage accessible on Church Street, north of Maitland Street.
Who should I call to ask about financial aid or insurance network?
For general inquiries, email Sunnybrook Health Sciences Centre at questions@sunnybrook.ca. For patient care concerns or comments, contact the patient experience office at 416-480-4940. Financial assistance and community support inquiries can be directed to 2-1-1. For drug reimbursement, visit TG-230 in the Odette Cancer Centre or call 416-480-4623. The Sunnybrook Foundation can be reached at 416-480-4483 or visit www.sunnybrook.ca/foundation.
What insurance does Sunnybrook Health Sciences Centre accept?
Sunnybrook Health Sciences Centre accepts the Ontario Health Insurance Plan (OHIP) for eligible patients. Non-OHIP patients can access billing information and payment details for medical services. Patients should bring their health card, extended health insurance policy information, and motor vehicle insurance provider details to their first appointment.
What awards or recognition has Sunnybrook Health Sciences Centre received?
Sunnybrook Health Sciences Centre, located in Toronto, Ontario, is a world-leading healthcare institution and a fully affiliated teaching hospital of the University of Toronto. It is renowned for its groundbreaking healthcare research, significantly impacting global patient treatment. The Sunnybrook Research Institute boasts over 360 scientists, 11 Canada Research Chairs, involvement in 500+ active clinical trials, 1700 annual publications, and the establishment of 20 start-up companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.